IRIS - Res&Arch Institutional Research Information System - Research & Archive

VEDOVATI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.830
EU - Europa 1.222
AS - Asia 712
SA - Sud America 19
AF - Africa 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.817
IE - Irlanda 376
SG - Singapore 355
IT - Italia 339
HK - Hong Kong 125
UA - Ucraina 119
SE - Svezia 98
CN - Cina 96
VN - Vietnam 87
FI - Finlandia 74
RU - Federazione Russa 59
DE - Germania 46
FR - Francia 34
GB - Regno Unito 24
TR - Turchia 19
BR - Brasile 17
BE - Belgio 10
CA - Canada 9
KR - Corea 9
AT - Austria 7
CH - Svizzera 7
UZ - Uzbekistan 6
ES - Italia 4
GR - Grecia 4
JP - Giappone 4
LB - Libano 4
NL - Olanda 4
PL - Polonia 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
MX - Messico 3
RO - Romania 3
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AI - Anguilla 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
EG - Egitto 1
HR - Croazia 1
IN - India 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
TW - Taiwan 1
VE - Venezuela 1
Totale 3.790
Salva come PNG Salva come JPEG
Città #
Dublin 376
Chandler 325
Singapore 278
San Mateo 176
Boardman 125
Hong Kong 125
Altamura 121
Santa Clara 109
Perugia 106
Ann Arbor 91
Medford 90
Princeton 90
Lawrence 89
Dong Ket 86
Jacksonville 61
Wilmington 48
Andover 46
Beijing 39
Redmond 36
Des Moines 30
Los Angeles 22
Redwood City 19
Saint Petersburg 19
Helsinki 15
Izmir 15
Norwalk 14
San Paolo di Civitate 14
Woodbridge 14
Amelia 13
Ashburn 11
Rome 11
Brussels 10
Seoul 9
Shanghai 9
New York 8
Moscow 7
Lappeenranta 6
Falls Church 4
Gainesville 4
Lausanne 4
Ottawa 4
Tokyo 4
Toledo 4
Bologna 3
Clifton 3
Den Haag 3
London 3
Milan 3
Nanning 3
Nuremberg 3
Sofia 3
Toronto 3
Bad Muenstereifel 2
Córdoba 2
Dallas 2
Frankfurt Am Main 2
Frankfurt am Main 2
Garbagnate Milanese 2
Guangzhou 2
Gunzenhausen 2
Houston 2
Loma Linda 2
Madrid 2
Menlo Park 2
Munich 2
Piediluco 2
Pisa 2
Rostock 2
Salerno 2
Simi Valley 2
São Paulo 2
Aberdeen 1
Acerra 1
Acquasparta 1
Albignasego 1
Amargosa 1
Amsterdam 1
Angra dos Reis 1
Aryanah 1
Athens 1
Auburn Hills 1
Auckland 1
Augusta 1
Baku 1
Belo Horizonte 1
Bishkek 1
Brescia 1
Buena Nueva 1
Buggiano 1
Cairo 1
Campinas 1
Campo Grande 1
Changsha 1
Chengdu 1
Chennai 1
Chongqing 1
Clearwater 1
Colombo 1
Corbélia 1
Criciúma 1
Totale 2.781
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 99
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 95
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 88
Thrombophilia and cerebral vein thrombosis 79
Aspirin for preventing the recurrence of venous thromboembolism. 73
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 73
Antecolic or Retrocolic Alimentary Limb in Laparoscopic Roux-en-Y Gastric Bypass? A Meta-Analysis 65
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 63
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 62
Combined oral anticoagulants and antiplatelets: benefits and risks. 61
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 59
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 58
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 57
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 56
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 56
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 54
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 53
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 52
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 51
[2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism: what's new?] 51
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 50
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 50
Reply 50
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 50
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 49
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 49
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 49
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 48
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 48
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 47
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation 47
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 46
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 45
Carotid plaque detection improves the predictve value of CHA 2 DS 2 -VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 45
A new strategy for anticoagulation: The factor XI inhibitors 44
Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. 44
Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight 43
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 43
Patients with acute pulmonary embolism at intermediate risk for death: Can we further stratify? 43
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 42
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 41
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 40
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 40
Beyond the guidelines: Novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism 40
Intra-abdominal drainage after pancreatic resection: Is it really necessary? A meta-analysis of short-term outcomes 40
Old and new oral anticoagulants forvenous thromboembolism and atrial fibrillation: A review of the literature. 39
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 39
To drain or not to drain elective uncomplicated laparoscopic cholecystectomy? A systematic review and meta-analysis 38
Predictors of new onset atrial fibrillation after myocardial infarction 38
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 38
Multidetectorcomputed tomography for acute pulmonary embolism: diagnosis and riskstratification in a single test. 37
One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study 37
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 37
MDCT-detected embolic burden and clinical outcome in patients with acute pulmonary embolism 37
Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. 36
Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. 36
To drain or not to drain extraperitoneal colorectal anastomosis? A systematic review and meta-analysis. 36
Thrombotic risk after a major bleeding during anticoagulation: A clinical case 36
A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer 36
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 36
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 35
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study 35
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants 35
Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. 34
Prognostic value of troponins in acutepulmonary embolism: a meta-analysis. 34
Right ventricle dysfunction in patients with pulmonary embolism. 33
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 33
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 33
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study 32
Prognostic value of the CHA2DS2Vasc score in patients experiencing a myocardial infarction 31
Accuracy of Physicians in Differentiating Type 1 and Type 2 Myocardial Infarction Based on Clinical Information 31
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 31
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis 30
Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: A case report 30
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management 29
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 28
Efficacy and safety of direct oral anticoagulants after pulmonary embolism: A meta-analysis 27
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 27
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 26
Novel oral anticoagulants for patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 26
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. 25
Novel oral anticoagulants in patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 25
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 24
Efficacy and safety of novel oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis 23
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study 20
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE 19
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 18
Shock and diffuse ST-elevation in a patient with coronavirus disease-2019 disease 18
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 17
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis 15
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism 15
Patients with Atrial Fibrillation receiving NOACs: The boundary between appropriate and inappropriate dose 15
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 15
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 14
Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study 14
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 13
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 12
[Anticoagulation therapy during pulmonary embolism follow-up in clinical practice] 12
[A new anticoagulant strategy: the factor XI inhibitors] 12
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 11
Totale 3.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 0 1 17 9 26 42 11 5
2020/2021462 3 22 12 18 181 28 28 14 29 13 25 89
2021/2022693 7 126 8 20 32 4 8 206 24 59 91 108
2022/20231.272 94 293 18 71 76 121 0 45 493 5 33 23
2023/2024496 26 54 29 9 6 1 107 3 41 35 104 81
2024/2025575 18 130 45 89 238 55 0 0 0 0 0 0
Totale 4.022